Comparison of white tea, green tea, epigallocatechin-3-gallate, and caffeine as inhibitors of PhIP-induced colonic aberrant crypts

Nutrition and Cancer

Volumn 58, Issue 1, 2007, Pages 60-65

  Carter, Orianna ^a   Wang, Rong ^b   Dashwood, W Mohaiza ^b   Orner, Gayle A ^b   Fischer, Kay A ^c   Löhr, Christiane V ^c   Pereira, Clifford B ^c   Bailey, George S ^b   Williams, David E ^b   Dashwood, Roderick H ^b  

^a Ohio University Southern   (United States)

^b OREGON STATE UNIVERSITY   (United States)

^c OREGON STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINO 1 METHYL 6 PHENYLIMIDAZO[4,5 B]PYRIDINE; BROXURIDINE; CAFFEINE; CASPASE 3; DRUG METABOLIZING ENZYME; EPIGALLOCATECHIN GALLATE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER PREVENTION; CELL LABELING; CELL PROLIFERATION; COLON CARCINOGENESIS; COMPARATIVE STUDY; CONTROLLED STUDY; CRYPT CELL; ENZYME ASSAY; ENZYME INDUCTION; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; RAT; TEA;

RATTUS;

EID: 34447514255     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1080/01635580701308182     Document Type: Article

References (17)

1. Lambert JD, Hong J, Yang GY, Liao J, and Yang CS: Inhibition of carcinogenesis by polyphenols: evidence from laboratory investigations. Am J Clin Nutr 81, 284S-291S, 2005.
2. Santana-Rios G, Orner GA, Amantana A, Provost C, Wu S-Y, and Dashwood RH: Potent antimutagenic activity of white tea in comparison with green tea in the Salmonella assay. Mutat Res 495, 61-74, 2001.
3. min mouse: down-regulation of β-catenin signaling by a combination of tea plus sulindac. Carcinogenesis 24, 263-267, 2003.
4. Santana-Rios G, Orner GA, Xu M, Izquierdo-Pulido M, and Dashwood RH: Inhibition by white tea of 2-amino-1-methyl-6-phenylimidazo[4,5-b] pyridine-induced colonic aberrant crypts in the F344 rat. Nutr Cancer 41, 98-103, 2001.
5. Xu M, Chen R, Dashwood RH: Effect of carcinogen dose fractionation, diet, and source of F344 rat on the induction of colonic aberrant crypts by 2-amino-3-methylimidazo[4,5-f]quinoline. Carcinogenesis 20, 2293-2298, 1999.
6. Tachino N, Hayashi R, Liew C, Bailey G, and Dashwood R: Evidence for ras gene mutation in 2-amino-3-methylimidazo[4,5-f]quinoline-induced colonic aberrant crypts. Mol Carcinogen 12, 187-192, 1995.
7. Xu M, Bailey AC, Hernaez JF, Taoka CR, Schut HAJ, and Dashwood RH: Protection by green tea, black tea, and indole-3-carbinol against 2-amino-3-methylimidazo[4,5-f]quinoline-induced DNA adducts and colonic aberrant crypts in the F344 rat. Carcinogenesis 17, 1429-1434, 1996.
8. Dashwood RH, Xu M, and Horio D: Colonic cell proliferation, apoptosis and aberrant crypt development in rats given 2-amino-3-methylimidazo[4,5-f] quinoline and treated post-initiation with chlorophyllin. Eur J Cancer Prev 10, 139-145, 2001.
9. McLellan EA, Medline A, and Bird RP: Dose response and proliferative characteristics of aberrant crypt foci: putative preneoplastic lesions in rat colon. Carcinogenesis 12, 2093-2098, 2001.
10. Volate SR, Davenport DM, Muga SJ, and Wargovich MJ: Modulation of aberrant crypt foci and apoptosis by dietary herbal supplements (quercetin, curcumin, silymarin, ginseng and rutin). Carcinogenesis 26, 1450-1456, 2005.
11. Wargovich MJ, Chen CD, Gray K, and Kelloff GJ: Aberrant crypts as a biomarker for colon cancer: evaluation of potential chemopreventive agents in the rat. Cancer Epidemiol Biomarkers Prev 5, 355-360, 1996.
12. Suganuma M, Okabe S, Kai Y, Sueoka N, Sueoka E, and Fujiki H: Synergistic effects of (-)-epigallocatechin gallate with (-)-epicatechin, sulindac, or tamoxifen on cancer-preventive activity in the human lung cancer cell line PC-9. Cancer Res 59, 44-47, 1999.
13. Takeshita F, Ogawa K, Asamoto M, and Shirai T: Mechanistic approach of contrasting modifying effects of caffeine on carcinogenesis in the rat colon and mammary gland induced with 2-amino-1-methyl-6-phenylimidazo[4,5-b] pyridine. Cancer Lett 194, 25-35, 2003.
14. Tsuda H, Sekine K, Uehara N, Takasuka N, Moore MA, Konno Y, Nakashita K, and Dcgawa M: Heterocyclic amine mixture carcinogenesis and its enhancement by caffeine in F344 rats. Cancer Lett 143, 229-234, 1999.
15. Blum CA, Xu M, Orner GA, Fong AT, Bailey OS, Stoner GD, Horio DT, and Dashwood RH: β-catenin mutation in rat colon tumors initiated with 1,2-dimethylhydrazine or 2-amino-3-methylimidazo[4,5-f]quinoline, and the effect of post-initiation treatment with chlorophyllin and indole-3-carbinol. Carcinogenesis 22, 315-320, 2001.
16. Blum CA, Tanaka T, Zhong X, Li Q, Dashwood WM, Pereira C, Xu M, and Dashwood RH: Mutational analysis of Ctnnb1 and Apc in tumors from rats given 1,2-dimethylhydrazine or 2-amino-3-methylimidazo[4,5-f] quinoline: Mutational 'hot-spots' and the relative expression of β-catenin and c-Jun. Mol Carcinog 36, 195-203. 2003.
17. Wang R, Dashwood WM, Bailey GS, Williams DE, and Dashwood RH: Tumors from rats given 1,2-dimethylhydrazine plus chlorophyllin or indole-3-carbinol contain transcriptional changes in β-catenin that are independent of β-catenin mutation status. Mutat Res 610, 11-18, 2006.